Review: Reishi Mushroom and Blood Sugar Regulation Research
A 2015 comprehensive review in Functional Foods in Health and Disease examined research on Reishi (Ganoderma lucidum) and related species for their effects on blood sugar management and insulin sensitivity.
Study Design
Researchers analyzed multiple studies investigating how Ganoderma mushrooms affect glucose metabolism. The review examined both polysaccharide and triterpene compounds, looking at mechanisms including glucose uptake, insulin sensitivity, and pancreatic beta-cell function.
Key Findings
Multiple bioactive compounds from Reishi demonstrated potential for supporting healthy blood sugar levels. Polysaccharides appeared to help regulate glucose metabolism through several pathways, while triterpenes showed effects on improving insulin sensitivity. The research suggested these compounds may work through different but complementary mechanisms.
Broader Health Context
Blood sugar regulation affects nearly every aspect of health beyond diabetes risk. Stable glucose levels support consistent energy throughout the day, balanced mood, optimal cognitive function, and healthy weight management. These findings add to Reishi’s traditional reputation as a whole-body tonic mushroom.
Limitations to Consider
Most studies reviewed were preclinical, and optimal dosing for humans remains unclear. Individual responses vary significantly. Anyone taking diabetes medications should consult their healthcare provider before adding Reishi, as potential blood sugar effects could interact with existing treatments.
Citation: Ma, H.T., et al. (2015). Mushrooms of the Genus Ganoderma Used to Treat Diabetes and Insulin Resistance. Functional Foods in Health and Disease, 5(5), 161-183.